APA (7th ed.) Citation

Yu, J., Yin, L., Wang, Q., Liu, J., Zhang, L., Ye, H., . . . He, X. (2024). 70P Hypofractionated radiotherapy in combination with PD-1 inhibitors, GM-CSF and thymosin α1 in advanced relapsed metastatic solid tumors: An interim analysis of a single-arm phase II multicenter prospective clinical study. Annals of Oncology, 35, S1431. https://doi.org/10.1016/j.annonc.2024.10.091

Chicago Style (17th ed.) Citation

Yu, J., et al. "70P Hypofractionated Radiotherapy in Combination with PD-1 Inhibitors, GM-CSF and Thymosin α1 in Advanced Relapsed Metastatic Solid Tumors: An Interim Analysis of a Single-arm Phase II Multicenter Prospective Clinical Study." Annals of Oncology 35 (2024): S1431. https://doi.org/10.1016/j.annonc.2024.10.091.

MLA (9th ed.) Citation

Yu, J., et al. "70P Hypofractionated Radiotherapy in Combination with PD-1 Inhibitors, GM-CSF and Thymosin α1 in Advanced Relapsed Metastatic Solid Tumors: An Interim Analysis of a Single-arm Phase II Multicenter Prospective Clinical Study." Annals of Oncology, vol. 35, 2024, p. S1431, https://doi.org/10.1016/j.annonc.2024.10.091.